Pacira BioSciences, Inc. (PCRX) › Shareholders' EquityPacira BioSciences, Inc. (PCRX) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2008: $7.49M2009: -$22.95M2010: -$48.38M2011: $48.27M2012: $65.86M2013: $41.25M2014: $171.15M2015: $218.39M2016: $218.98M2017: $279.48M2018: $321.23M2019: $354.94M2020: $619.69M2021: $730.41M2022: $775.01M2023: $870.13M2024: $778.35M2025: $693.11M$693.11M2008Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$693.11M-11.0%2024$778.35M-10.5%2023$870.13M+12.3%2022$775.01M+6.1%2021$730.41M+17.9%2020$619.69M+74.6%2019$354.94M+10.5%2018$321.23M+14.9%2017$279.48M+27.6%2016$218.98M+0.3%2015$218.39M+27.6%2014$171.15M+314.9%2013$41.25M-37.4%2012$65.86M+36.4%2011$48.27M+199.8%2010-$48.38M-110.8%2009-$22.95M-406.4%2008$7.49M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share